Swedish investigation spoils Macchiarini cover-up at Lancet
NPOF, again and again: “Philipp Jungebluth and Paolo Macchiarini guilty of research misconduct” Lancet: “Paolo Macchiarini is not guilty of scientific misconduct”
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
NPOF, again and again: “Philipp Jungebluth and Paolo Macchiarini guilty of research misconduct” Lancet: “Paolo Macchiarini is not guilty of scientific misconduct”
Schneider Shorts 28.07.2023 – shocking practices at Shock, forged clinical trials in Italy exposed by UK academics, another phony superconductor announced, two clever methods to prevent Alzheimer’s, an unusual way to earn with scamferences, and finally, London professor’s quack scam under investigation.
“The only difficult part might be deciding whether Ken has been intentionally deceptive or wildly incompetent, although the difference in practice doesn’t seem so important.” – Sholto David
Schneider Shorts 7.07.2023 – MDPI internal file leaked, editors attempting to rat out whistleblowers, scientists proud of IAAM awards, Nobelitis strikes again, with cloning fraudster’s new business, biotech’s new anti-aging drug, bad rector in Sicily, and finally, one honest researcher demanding retraction of his own paper.
“This is gold, Mr. Bond. All my life I’ve been in love with its colour… its brilliance, its divine heaviness.”
“…the best evidence for the existence of VSELs is the dismal failure of all the other much-vaunted stem-cell therapies to deliver on their promises. Since it is axiomatic that some stem-cell therapy must work, the successful cell-types must be the ones that haven’t been tried yet, which leaves VSELs.”- Smut Clyde
Schneider Shorts 3.03.2023 – Lab leak theory of COVID-19 escapes peer review, sadist professor in Germany (almost) exposed, various takes on the usefulness of academic friendship, with a stem cell breakthrough, Lancet and COPE bashed, and finally, why single men smell so nice.
Everyone is talking about Stanford’s President Marc Tessier-Lavigne now. OK, let’s talk about him, and how Stanford deals with research fraud. And then let’s talk about Thomas Rando.
“As pioneers in the field of regenerative medical therapies, we at Direct Biologics are changing the future of medicine.”
Schneider Shorts 24.06.2022 – bad choices in Dresden end with research misconduct findings, where the money for heart stem cell research went, nicotine and Photoshop fraud fail in clinical trials, with the most authoritative papermill guidelines, a coronavirus zapper from Italy, and a plant science professor who wasn’t so great after all.
Have a WordPress.com account? Log in now.






